Craig-Hallum analyst Alex Fuhrman maintained a Buy rating on LifeMD (LFMD – Research Report) today. The company’s shares closed last Friday at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback